{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-000818","form_type":"8-K","ticker":"APRE","cik":"0001781983","company_name":"Aprea Therapeutics, Inc.","filed_at":"2024-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.507612+00:00","generated_at":"2026-06-06T08:22:35.680635+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Aprea Therapeutics updates corporate presentation; no material new information disclosed","bullets":["Filed an updated corporate presentation slide deck on February 6, 2024.","No specific financial results, clinical data, or strategic changes in the filing.","Presentation likely includes general company overview and pipeline summary.","No guidance, milestones, or forward-looking updates provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-000818","json":"https://secwatch.observer/filing/0001558370-24-000818.json","markdown":"https://secwatch.observer/filing/0001558370-24-000818.md","text":"https://secwatch.observer/filing/0001558370-24-000818.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1781983/000155837024000818/0001558370-24-000818-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1781983/000155837024000818/apre-20240206x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T08:22:35.680635+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}